PMV Pharmaceuticals, Inc.
PMVP
$1.38
$0.042.61%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 13.99% | 8.02% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.73% | -1.16% | |||
| Operating Income | 0.73% | 1.16% | |||
| Income Before Tax | -0.25% | -0.15% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -0.27% | -0.01% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.27% | -0.01% | |||
| EBIT | 0.73% | 1.16% | |||
| EBITDA | 0.67% | 1.17% | |||
| EPS Basic | -0.18% | 0.24% | |||
| Normalized Basic EPS | -0.14% | 0.09% | |||
| EPS Diluted | -0.18% | 0.24% | |||
| Normalized Diluted EPS | -0.14% | 0.09% | |||
| Average Basic Shares Outstanding | 0.10% | 0.25% | |||
| Average Diluted Shares Outstanding | 0.10% | 0.25% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||